middle.news
Orthocell Expands Stake to Unlock Global Rights for PearlBone Bone Regeneration Tech
9:03am on Monday 20th of October, 2025 AEDT
•
Healthcare
Read Story
Orthocell Expands Stake to Unlock Global Rights for PearlBone Bone Regeneration Tech
9:03am on Monday 20th of October, 2025 AEDT
Key Points
Orthocell increases equity stake in Marine Biomedical from 1.7% to 12%
Secures exclusive first right of refusal for global distribution of PearlBone™
PearlBone™ is a next-generation bone substitute derived from sustainably sourced pearl shells
Marine Biomedical targets FDA 510(k) submission in early 2026 for US market entry
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE